Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
117M
-
Number of holders
-
105
-
Total 13F shares, excl. options
-
65.5M
-
Shares change
-
-588K
-
Total reported value, excl. options
-
$231M
-
Value change
-
-$18.6M
-
Put/Call ratio
-
0.73
-
Number of buys
-
46
-
Number of sells
-
-52
-
Price
-
$3.53
Significant Holders of DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) as of Q1 2020
137 filings reported holding DVAX - DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value as of Q1 2020.
DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) has 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.5M shares
of 117M outstanding shares and own 55.89% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (9.77M shares), Bain Capital Life Sciences Investors, LLC (8.73M shares), BlackRock Inc. (5.97M shares), VANGUARD GROUP INC (4.44M shares), Chicago Capital, LLC (4.22M shares), Avidity Partners Management LP (3.82M shares), STATE STREET CORP (3.42M shares), Bain Capital Public Equity Management II, LLC (2.88M shares), BLAIR WILLIAM & CO/IL (2M shares), and D. E. Shaw & Co., Inc. (1.65M shares).
This table shows the top 105 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.